Related content

Psoriasis disease severity measures: comparing efficacy of treatments for severe psoriasis

By Weisman S   Pollack CR   Gottschalk RW  

Journal of Dermatological Treatment, Vol. 14, Iss. 3, 2003-09 ,pp. : 158-165

Informa Healthcare

Access to resources Recommend Favorite

Topical TrkA Kinase Inhibitor CT327 is an Effective, Novel Therapy for the Treatment of Pruritus due to Psoriasis: Results from Experimental Studies, and Efficacy and Safety of CT327 in a Phase 2b Clinical Trial in Patients with Psoriasis

By Roblin David   Yosipovitch Gil   Boyce Brent   Robinson John   Sandy James   Mainero Valentina   Wickramasinghe Ro   Anand Uma   Anand Praveen  

Acta Dermato-Venereologica, Vol. 95, Iss. 5, 2015-05 ,pp. : 542-548

Medical Journals Limited

Access to resources Recommend Favorite

Safe Psoriasis Control: A New Outcome Measure for the Composite Assessment of the Efficacy and Safety of Psoriasis Treatment

By Papp Kim   Henninger Eric  

Journal of Cutaneous Medicine and Surgery, Vol. 9, Iss. 6, 2005-12 ,pp. : 276-283

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy of adalimumab in the treatment of psoriasis: A retrospective study of 15 patients in daily practice

By Sola-Ortigosa Joaquín   Sánchez-Regaña Manuel   Umbert-Millet Pablo  

Journal of Dermatological Treatment, Vol. 23, Iss. 3, 2012-06 ,pp. : 203-207

Informa Healthcare

Access to resources Recommend Favorite

Cost-efficacy comparison of biological therapies for patients with moderate to severe psoriasis in Japan

By Igarashi Atsuyuki   Kuwabara Hiroyo   Fahrbach Kyle   Schenkel Brad  

Journal of Dermatological Treatment, Vol. 24, Iss. 5, 2013-10 ,pp. : 351-355

Informa Healthcare

Access to resources Recommend Favorite